Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Study supports halting antiseizure medications after neonatal seizures

Publish date:: October 27, 2020

Key clinical point: Halting antiseizure medications is safe after acute symptomatic neonatal seizures.

Major finding: Functional development measures were similar with discontinued and maintenance therapy.

Study details: Prospective, observational, comparative effectiveness study of 270 patients at nine centers enrolled in the Neonatal Seizure Registry.

Disclosures: The study was funded by the Patient-Centered Outcomes Research Institute (PCORI) and the Pediatric Epilepsy Research Foundation. Dr. Glass has no other financial relationships to disclose.

Citation:

Glass HC et al. CNS-ICNA 2020. Presentation PL58.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Epilepsy & Seizures

Study supports halting antiseizure medications after neonatal seizures,

CBD for LGS: Fewer seizures, but thrombocytopenia risk,

Preventive treatment delays first seizure onset in tuberous sclerosis complex,

Listening to Mozart helps tame epilepsy,

In epilepsy, brain-responsive stimulation passes long-term tests,